Flu drug ‘favipiravir’ hailed as effective for treating COVID-19
Category: #health  By Pankaj Singh  Date: 2020-03-19
  • share
  • Twitter
  • Facebook
  • LinkedIn

Flu drug ‘favipiravir’ hailed as effective for treating COVID-19

Medical authorities in China have reportedly announced the effectiveness of a drug called favipiravir in treating COVID-19 disease. The drug has originally been adopted for the treatment of new strains of influenza in Japan. According to reliable sources, coronavirus infected patients in Shenzen who have been treated with the drug, have apparently shown positive outcomes.

As per the statement made by Zhang Xinmin, director of National Center for Biotechnology Development in China, the clinical trials for the favipiravir drug in Shenzen and Wuhan has yielded positive outcomes. 340 patients are said to have participated in the clinical trial of the drug. Zhang further added that this drug could prove effective for the treatment of the deadly coronavirus that has been spreading across the globe. The drug also possesses a high degree of safety for consumption by the infected patients.

Favipiravir, also known as Avigan, is an antiviral drug developed by Fujifilm’s subsidiary against RNA viruses, which has been proved effective for treating flu. The patients who took part in the trial have turned negative for the disease after a median of 4 days, which normally takes nearly 11 days for patients without favipiravir treatment. In addition, X-rays revealed that around 91% of the patients who were treated with the drug have shown improved conditions of their lungs, as compared to the normal level or chances of 62% improvement among patients without the usage of favipiravir.

The World Health Organization (WHO) has declared coronavirus that has been sweeping across the globe as a pandemic and as a global public health emergency. Nearly 200,000 people across the globe have been infected by the deadly virus, with around 8,000 reported deaths. The WHO is also closely monitoring the outbreak due to the alarming levels of severity and spread of the pandemic. Major affected regions outside of the mainland China include Italy, the U.S, and South Korea.

Source credits:

https://www.cnbc.com/2020/03/18/coronavirus-japanese-flu-drug-could-be-effective-in-treating-pandemic.html



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Appili gets FDA approval to expand the clinical trial of favipiravir
Appili gets FDA approval to expand the clinical trial of favipiravir
By Pankaj Singh

Biopharmaceutical major, Appili Therapeutics Inc., has reportedly announced that it has received the approval of the U.S. Food and Drug Administration (FDA) over its recently filed investigational new drug application ...

Saudi begins Phase III clinical trials of Chinese COVID-19 vaccine
Saudi begins Phase III clinical trials of Chinese COVID-19 vaccine
By Pankaj Singh

The Ministry of Health, Saudi Arabia, has reportedly announced that it will begin the third phase of clinical trials for a COVID-19 vaccine, as part of its cooperation with China’s CanSino Biologics Inc. The tria...

Amazon cleared by UK regulators to buy 16% stake in Deliveroo
Amazon cleared by UK regulators to buy 16% stake in Deliveroo
By Pankaj Singh

The eCommerce giant Amazon has been granted permission to purchase a minority stake in the U.K-based food delivery start-up Deliveroo. The firm was able to convince regulators that the deal would not be detrimental to ...